In this trial, individuals who received Wegovy lost 6.2% of their initial body weight compared to those who received a placebo
There are no "off days" where the medication effect diminishes
Reducing from 1 mg to 0.5 mg, or from 2 mg to 1 mg, is a perfectly valid approach
Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World Company profiles of the GLP-1 Analogues market and the growth strategies adopted by the market players to sustain the fast-growing market
As evidence from ongoing clinical trials and real-world studies accumulates, future guidelines are expected to evolve toward more personalized and comprehensive strategies for DKD management
This is exactly why this conversation belongs in a rheumatologists office